Back to my company list

e-NIOS

The AI engine Fit Assessment

Beta

e-NIOS leverages machine learning for genomic data analysis, enabling the discovery of new patterns and the development of novel therapeutics.

Blurb

e-NIOS delivers unsupervised interpretation of genomic data

HQ Location

Kallithea (Greece)

Founded

2014

Employees

1 - 10

Total funding raised

$233.37K

Funding Status

Seed, $109.31K, January 10, 2016
Subspaces
  • Genomic Data Analysis
  • Biomarker Identification

Reproducible -omics data interpretation, i.e. the derivation of actionable molecular biomarkers, is currently the main bottleneck in streamlined applications, obstructing the transformation of genomic information into insights for Biomedicine and Biotech.



BioInfoMiner delivers unsupervized, fast and integrative interpretation of -omics experiments, in the form of biomarker signatures. Prioritized genes are mapped to few, clear, systemic pathways and phenotypes, enabling seamless biomarker identification and prioritization.